Hannah Valantine - 28 Dec 2021 Form 4/A - Amendment Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Hannah A. Valantine, M.D.
Issuer symbol
BBIO
Transactions as of
28 Dec 2021
Net transactions value
+$30,028
Form type
4/A - Amendment
Filing time
30 Jun 2025, 17:46:18 UTC
Date Of Original Report
13 Feb 2024
Previous filing
26 Oct 2021
Next filing
30 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Valantine Hannah Director C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO /s/ Hannah A. Valantine, M.D. 30 Jun 2025 0001855608

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Purchase $19,553 +1,542 $12.68 1,542 28 Dec 2021 Direct
transaction BBIO Common Stock Purchase $10,475 +796 +42% $13.16 2,687 28 Dec 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.